Medical Devices Australia

Australia Focused Ultrasound Therapy Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

Australia Focused Ultrasound Therapy Market Industry Trends and Forecast to 2034: Segmented by (Application, Technology, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Australia · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $4.6 Mn Placeholder estimate
Estimate 2025 $5.1 Mn 1.4% of the global market
Projected 2034 $13.4 Mn 164.2% Adds $8.4 Mn over 9 forecast years
CAGR 2025–2034 11.4% Faster than 63% of 186 Medical Devices markets here
Key players 5
  • Australia is 1.4% of the global market.
  • In APAC, the largest is China at $33.2 Mn.
  • Fastest growing: India at 13.1% a year.
  • Australia ranks 4th of 10 by size in APAC.

Market size projection

Australia

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$8.4 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Focused Ultrasound Therapy Market market size by year, Australia
YearMarket sizeChange that yearSince 2025
2024 (estimate) $4.6 Mn — —
2025 (base) $5.1 Mn +$0.5 Mn —
2026 (forecast) $5.7 Mn +$0.6 Mn +11.4%
2027 (forecast) $6.3 Mn +$0.6 Mn +24.1%
2028 (forecast) $7.0 Mn +$0.7 Mn +38.2%
2029 (forecast) $7.8 Mn +$0.8 Mn +54%
2030 (forecast) $8.7 Mn +$0.9 Mn +71.6%
2031 (forecast) $9.7 Mn +$1.0 Mn +91.1%
2032 (forecast) $10.8 Mn +$1.1 Mn +112.9%
2033 (forecast) $12.1 Mn +$1.2 Mn +137.2%
2034 (forecast) $13.4 Mn +$1.4 Mn +164.2%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

Australia Focused Ultrasound Therapy Market Analysis at a glance
Market size, 2025$5.1 Mn placeholder estimate
Forecast, 2034$13.4 Mn placeholder estimate
Growth (CAGR), 2025–203411.4% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsApplication, technology and end user (see all)
Key playersInsightec, Profound Medical, SonaCare Medical, EDAP TMS, Philips Healthcare (see all)
Regulator in AustraliaTGASource: Therapeutic Goods Administration. Checked 14 Nov 2026.
Active clinical trials1 in AustraliaSource: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Australia. Retrieved 12 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Australia Focused Ultrasound Therapy Market Analysis Executive Summary

Focused ultrasound therapy uses sound waves guided by MRI to treat tremor, tumours and other conditions without cutting.

Key segments of the focused Ultrasound Therapy market include application (Neurological Disorders, Uterine Fibroids and Prostate) and technology (MR-Guided and Ultrasound-Guided).

Bar chart: Australia Focused Ultrasound Therapy market size, 2024–2034, placeholder estimates. $4.6 Mn in 2024, $5.1 Mn in 2025 and $13.4 Mn in 2034, 11.4% CAGR.
Australia Focused Ultrasound Therapy market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Australia Focused Ultrasound Therapy Market Dynamics

Market Growth Drivers

An ageing population, more people living with brain and nerve diseases, better diagnosis and the first disease-modifying treatments are driving the focused Ultrasound Therapy market.

Opportunity

Biomarker-guided treatment, earlier diagnosis and new device-based therapies give the focused Ultrasound Therapy market strong room to grow.

Market Restraints

Hard-to-reach brain targets, high failure rates in trials, side effects and high prices for new therapies hold back the focused Ultrasound Therapy market.

Competitive Landscape for Focused Ultrasound Therapy Market in Australia

The focused Ultrasound Therapy market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Focused Ultrasound Therapy Market in Australia

Focused Ultrasound Therapy in Australia: rules, payment and research

Medical devices must be included in the Australian Register of Therapeutic Goods (ARTG), run by the Therapeutic Goods Administration (TGA), before they can be supplied.⁠[1] Medicare pays for public hospital care and many doctor visits, and the Pharmaceutical Benefits Scheme (PBS) subsidises listed medicines.⁠[2] ClinicalTrials.gov lists 1 study on Focused Ultrasound Therapy that is recruiting, active or about to start in Australia.⁠[3]

[1] Therapeutic Goods Administration. Checked 14 Nov 2026.

[2] Pharmaceutical Benefits Scheme. Checked 14 Nov 2026.

[3] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Australia. Retrieved 12 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how focused Ultrasound Therapy products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Australia.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Focused Ultrasound Therapy right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Focused Ultrasound Therapy in context

Australia compared

  • Health spending per person: 6,980 US$ per person (2023). World: 1,317 US$ per person (2023). Highest of the 17 countries we cover in APAC.[1]
  • Doctors: 4.09 per 1,000 people (2022). World: 1.86 per 1,000 people (2022). Highest of the 17 countries we cover in APAC.[2]
  • People aged 65 and over: 18.1% of people (2025). World: 10.4% of people (2025). 4th highest of the 18 countries we cover in APAC.[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 20 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 21 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 21 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Focused Ultrasound Therapy market in Australia?
Placeholder estimate: about $5.1 Mn in 2025, rising to about $13.4 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Focused Ultrasound Therapy market in Australia growing?
Placeholder estimate: about 11.4% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Focused Ultrasound Therapy market report cover?
The report splits the market by application (Neurological Disorders, Uterine Fibroids, Prostate, Bone Metastases), technology (MR-Guided, Ultrasound-Guided) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Focused Ultrasound Therapy market?
Key players include Insightec, Profound Medical, SonaCare Medical, EDAP TMS and Philips Healthcare.
What is driving the Focused Ultrasound Therapy market?
An ageing population, more people living with brain and nerve diseases, better diagnosis and the first disease-modifying treatments are driving the focused Ultrasound Therapy market.
Who regulates Focused Ultrasound Therapy in Australia?
Medical devices must be included in the Australian Register of Therapeutic Goods (ARTG), run by the Therapeutic Goods Administration (TGA), before they can be supplied. Source: Therapeutic Goods Administration. Checked 14 Nov 2026.
How is healthcare paid for in Australia?
Medicare pays for public hospital care and many doctor visits, and the Pharmaceutical Benefits Scheme (PBS) subsidises listed medicines. Source: Pharmaceutical Benefits Scheme. Checked 14 Nov 2026.
How many clinical trials on Focused Ultrasound Therapy are running in Australia?
1 study is recruiting, active or about to start in Australia, according to ClinicalTrials.gov. Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Australia. Retrieved 12 Nov 2026.
How much research is published on Focused Ultrasound Therapy?
PubMed lists 137 papers on Focused Ultrasound Therapy added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Medical Devices reports in Australia

See all

Related on brain and nerves

See the topic